デフォルト表紙
市場調査レポート
商品コード
1233545

哺乳類セルバンキングの世界市場:癌の罹患率上昇、研究開発に対する政府の取り組み、凍結保存技術の向上が哺乳類細胞バンク市場の開拓に有利に働く

Rising prevalence of cancer, the initiative taken by the government for research and development activities, and improving Cryopreservation Technology will favor the Growth of the Mammalian Cell Banking Market

出版日: | 発行: Persistence Market Research | ページ情報: 英文 251 Pages | 納期: 2~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
哺乳類セルバンキングの世界市場:癌の罹患率上昇、研究開発に対する政府の取り組み、凍結保存技術の向上が哺乳類細胞バンク市場の開拓に有利に働く
出版日: 2023年01月23日
発行: Persistence Market Research
ページ情報: 英文 251 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の哺乳類セルバンキング市場について調査し、細胞別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

第4章 主な成功要因

第5章 市場の背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機- 影響評価

第7章 世界の哺乳類セルバンキング市場の需要分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測

第8章 世界の哺乳類セルバンキング市場の分析と予測:細胞別

  • イントロダクション/主な調査結果
  • 過去の市場分析: セル別
  • 現在および将来の市場分析と予測:セル別
    • CHO
    • BHK
    • NS0
    • YB2/0 &P2/0
    • HEK293 および誘導体
    • HELA
  • 市場魅力度分析:細胞別

第9章 世界の哺乳類セルバンキング市場の分析と予測:技術別

  • イントロダクション/主な調査結果
  • ヒストリカルマーケット:技術別
  • 現在および将来の市場分析と予測:技術別
    • TEP
    • IEP
    • SEP
  • 市場魅力分析:技術別

第10章 世界の哺乳類セルバンキング市場の分析と予測:用途別

  • イントロダクション/主な調査結果
  • 過去の市場分析: 用途別
  • 現在および将来の市場分析と予測: 用途別
    • MCB
    • WCB
    • EoP
    • 研究開発CB
  • 市場魅力度分析:用途別

第11章 世界の哺乳類セルバンキング市場の分析と予測:エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場: エンドユーザー別
  • 現在および将来の市場分析と予測:エンドユーザー別
    • 学術・調査機関
    • バイオ医薬品企業
    • CRO
  • 市場魅力分析:エンドユーザー別

第12章 世界の哺乳類セルバンキング市場の分析と予測:地域別

  • イントロダクション
  • 過去の市場分析:地域別
  • 現在の市場分析と予測:地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力度分析:地域別

第13章 北米の哺乳類セルバンキング市場の分析と予測

第14章 ラテンアメリカの哺乳類セルバンキング市場の分析と予測

第15章 欧州の哺乳類セルバンキング市場の分析と予測

第16章 南アジアの哺乳類セルバンキング市場の分析と予測

第17章 東アジアの哺乳類セルバンキング市場の分析と予測

第18章 オセアニアの哺乳類セルバンキング市場と予測

第19章 中東・アフリカの哺乳類細胞バンキング市場の分析と予測

第20章 市場構造分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合のベンチマーク
  • 競合の詳細
    • Eurofins DiscoverX Corporation
    • Merck KGaA
    • Sartorius Stedim BioOutsource Limited.
    • Charles River Laboratories
    • Altogen Labs
    • Abzena Ltd
    • Northway Biotechpharma
    • Lonza Group Ltd
    • VIRUSURE
    • Selexis SA
    • Sigma-Aldrich
    • Takara Bio Inc

第22章 使用される仮定と頭字語

第23章 調査手法

図表

List of Tables

  • Table 01: Global Mammalian Cell Banking Size (US$ Mn) Analysis and Forecast 2023-2033, By Cell
  • Table 02: Global Mammalian Cell Banking Size (US$ Mn) Analysis and Forecast 2023-2033, By Technology
  • Table 03: Global Mammalian Cell Banking Size (US$ Mn) Analysis and Forecast 2023-2033, By Application
  • Table 04: Global Mammalian Cell Banking Value (US$ Mn) Analysis and Forecast 2023-2033, By End User
  • Table 05: Global Mammalian Cell Banking Size (US$ Mn) Analysis and Forecast 2023-2033, By Region
  • Table 06: North America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Country
  • Table 07: North America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Cell
  • Table 08: North America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Technology
  • Table 09: North America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Application
  • Table 10: North America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By End User
  • Table 11: Latin America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Country
  • Table 12: Latin America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Cell
  • Table 13: Latin America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Technology
  • Table 14: Latin America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Application
  • Table 15: Latin America Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By End User
  • Table 16: Europe Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Country
  • Table 17: Europe Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Cell
  • Table 18: Europe Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Technology
  • Table 19: Europe Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Application
  • Table 20: Europe Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By End User
  • Table 21: South Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Country
  • Table 22: South Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Cell
  • Table 23: South Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Technology
  • Table 24: South Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Application
  • Table 25: South Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By End User
  • Table 26: East Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Country
  • Table 27: East Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Cell
  • Table 28: East Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Technology
  • Table 29: East Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Application
  • Table 30: East Asia Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By End User
  • Table 31: Oceania Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Country
  • Table 32: Oceania Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Cell
  • Table 33: Oceania Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Technology
  • Table 34: Oceania Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Application
  • Table 35: Oceania Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By End User
  • Table 36: Middle East & Africa Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Country
  • Table 37: Middle East & Africa Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Cell
  • Table 38: Middle East & Africa Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Technology
  • Table 39: Middle East & Africa Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By Application
  • Table 40: Middle East & Africa Mammalian Cell Banking Size Analysis 2015-2022 and Forecast 2023-2033, By End User

List of Figures

  • Figure 01: Global Mammalian Cell Banking Value Analysis (US$ Mn), 2015-2022
  • Figure 02: Global Mammalian Cell Banking Value Forecast (US$ Mn), 2023-2033
  • Figure 03: Global Mammalian Cell Banking Absolute $ Opportunity, 2022 - 2033
  • Figure 04: Global Mammalian Cell Banking Share Analysis (%), By Cell, 2023 & 2033
  • Figure 05: Global Mammalian Cell Banking Y-O-Y Analysis (%), By Cell, 2023-2033
  • Figure 06: Global Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 07: Global Mammalian Cell Banking Share Analysis (%), By Technology, 2023 & 2033
  • Figure 08: Global Mammalian Cell Banking Y-O-Y Analysis (%), By Technology, 2023-2033
  • Figure 09: Global Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 10: Global Mammalian Cell Banking Share Analysis (%), By Application, 2023 & 2033
  • Figure 11: Global Mammalian Cell Banking Y-O-Y Analysis (%), By Application, 2023-2033
  • Figure 12: Global Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 13: Global Mammalian Cell Banking Share Analysis (%), End User, 2023 & 2033
  • Figure 14: Global Mammalian Cell Banking Y-O-Y Analysis (%), End User, 2023-2033
  • Figure 15: Global Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 16: Global Mammalian Cell Banking Share Analysis (%), By Region, 2023 & 2033
  • Figure 17: Global Mammalian Cell Banking Y-O-Y Analysis (%), By Region, 2023-2033
  • Figure 18: Global Mammalian Cell Banking Attractiveness Analysis By Region, 2023-2033
  • Figure 19: North America Mammalian Cell Banking Value Share By Cell 2023 (E)
  • Figure 20: North America Mammalian Cell Banking Value Share By Technology 2023 (E)
  • Figure 21: North America Mammalian Cell Banking Value Share By Application 2023 (E)
  • Figure 22: North America Mammalian Cell Banking Value Share End User 2023 (E)
  • Figure 23: North America Mammalian Cell Banking Value Share By Country 2023 (E)
  • Figure 24: North America Mammalian Cell Banking Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 25: North America Mammalian Cell Banking Current and Future Market Size (US$ Mn), 2023-2033 & Y-O-Y Growth Trend Analysis
  • Figure 26: North America Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 27: North America Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 28: North America Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 29: North America Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 30: North America Mammalian Cell Banking Attractiveness Analysis By Country, 2023-2033
  • Figure 31: U.S. Market Value Proportion Analysis, 2022
  • Figure 32: U.S. Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 33: U.S. Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 34: U.S. Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 35: U.S. Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 36: Canada Market Value Proportion Analysis, 2022
  • Figure 37: Canada Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 38: Canada Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 39: Canada Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 40: Canada Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 41: Latin America Mammalian Cell Banking Value Share By Cell 2023 (E)
  • Figure 42: Latin America Mammalian Cell Banking Value Share By Technology 2023 (E)
  • Figure 43: Latin America Mammalian Cell Banking Value Share By Application 2023 (E)
  • Figure 44: Latin America Mammalian Cell Banking Value Share End User 2023 (E)
  • Figure 45: Latin America Mammalian Cell Banking Value Share By Country 2023 (E)
  • Figure 46: Latin America Mammalian Cell Banking Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 47: Latin America Mammalian Cell Banking Current and Future Market Size (US$ Mn), 2023-2033 & Y-O-Y Growth Trend Analysis
  • Figure 48: Latin America Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 49: Latin America Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 50: Latin America Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 51: Latin America Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 52: Latin America Mammalian Cell Banking Attractiveness Analysis By Country, 2023-2033
  • Figure 53: Brazil Market Value Proportion Analysis, 2022
  • Figure 54: Brazil Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 55: Brazil Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 56: Brazil Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 57: Brazil Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 58: Mexico Market Value Proportion Analysis, 2022
  • Figure 59: Mexico Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 60: Mexico Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 61: Mexico Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 62: Mexico Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 63: Brazil Market Value Proportion Analysis, 2022
  • Figure 64: Brazil Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 65: Brazil Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 66: Brazil Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 67: Brazil Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 68: Argentina Market Value Proportion Analysis, 2022
  • Figure 69: Argentina Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 70: Argentina Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 71: Argentina Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 72: Argentina Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 73: Europe Mammalian Cell Banking Value Share By Cell 2023 (E)
  • Figure 74: Europe Mammalian Cell Banking Value Share By Technology 2023 (E)
  • Figure 75: Europe Mammalian Cell Banking Value Share By Application 2023 (E)
  • Figure 76: Europe Mammalian Cell Banking Value Share End User 2023 (E)
  • Figure 77: Europe Mammalian Cell Banking Value Share By Country 2023 (E)
  • Figure 78: Europe Mammalian Cell Banking Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 79: Europe Mammalian Cell Banking Current and Future Market Size (US$ Mn), 2023-2033 & Y-O-Y Growth Trend Analysis
  • Figure 80: Europe Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 81: Europe Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 82: Europe Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 83: Europe Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 84: Europe Mammalian Cell Banking Attractiveness Analysis By Country, 2023-2033
  • Figure 85: Italy Market Value Proportion Analysis, 2022
  • Figure 86: Italy Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 87: Italy Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 88: Italy Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 89: Italy Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 90: Germany Market Value Proportion Analysis, 2022
  • Figure 91: Germany Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 92: Germany Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 93: Germany Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 94: Germany Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 95: U.K. Market Value Proportion Analysis, 2022
  • Figure 96: U.K. Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 97: U.K. Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 98: U.K. Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 99: U.K. Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 100: France Market Value Proportion Analysis, 2022
  • Figure 101: France Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 102: France Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 103: France Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 104: France Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 105: Spain Market Value Proportion Analysis, 2022
  • Figure 106: Spain Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 107: Spain Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 108: Spain Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 109: Spain Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 110: BENELUX Market Value Proportion Analysis, 2022
  • Figure 111: BENELUX Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 112: BENELUX Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 113: BENELUX Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 114: BENELUX Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 115: Nordic Countries Market Value Proportion Analysis, 2022
  • Figure 116: Nordic Countries Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 117: Nordic Countries Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 118: Nordic Countries Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 119: Nordic Countries Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 120: Russia Market Value Proportion Analysis, 2022
  • Figure 121: Russia Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 122: Russia Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 123: Russia Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 124: Russia Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 125: South Asia Mammalian Cell Banking Value Share By Cell 2023 (E)
  • Figure 126: South Asia Mammalian Cell Banking Value Share By Technology 2023 (E)
  • Figure 127: South Asia Mammalian Cell Banking Value Share By Application 2023 (E)
  • Figure 128: South Asia Mammalian Cell Banking Value Share End User 2023 (E)
  • Figure 129: South Asia Mammalian Cell Banking Value Share By Country 2023 (E)
  • Figure 130: South Asia Mammalian Cell Banking Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 131: South Asia Mammalian Cell Banking Current And Future Market Size (US$ Mn), 2023-2033 & Y-O-Y Growth Trend Analysis
  • Figure 132: South Asia Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 133: South Asia Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 134: South Asia Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 135: South Asia Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 136: South Asia Mammalian Cell Banking Attractiveness Analysis By Country, 2023-2033
  • Figure 137: India Market Value Proportion Analysis, 2022
  • Figure 138: India Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 139: India Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 140: India Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 141: India Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 142: Indonesia Market Value Proportion Analysis, 2022
  • Figure 143: Indonesia Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 144: Indonesia Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 145: Indonesia Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 146: Indonesia Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 147: Malaysia Market Value Proportion Analysis, 2022
  • Figure 148: Malaysia Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 149: Malaysia Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 150: Malaysia Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 151: Malaysia Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 152: Thailand Market Value Proportion Analysis, 2022
  • Figure 153: Thailand Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 154: Thailand Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 155: Thailand Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 156: Thailand Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 157: East Asia Mammalian Cell Banking Value Share By Cell 2023 (E)
  • Figure 158: East Asia Mammalian Cell Banking Value Share By Technology 2023 (E)
  • Figure 159: East Asia Mammalian Cell Banking Value Share By Application 2023 (E)
  • Figure 160: East Asia Mammalian Cell Banking Value Share End User 2023 (E)
  • Figure 161: East Asia Mammalian Cell Banking Value Share By Country 2023 (E)
  • Figure 162: East Asia Mammalian Cell Banking Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 163: East Asia Mammalian Cell Banking Current And Future Market Size (US$ Mn), 2023-2033 & Y-O-Y Growth Trend Analysis
  • Figure 164: East Asia Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 165: East Asia Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 166: East Asia Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 167: East Asia Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 168: East Asia Mammalian Cell Banking Attractiveness Analysis By Country, 2023-2033
  • Figure 169: China Market Value Proportion Analysis, 2022
  • Figure 170: China Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 171: China Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 172: China Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 173: China Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 174: Japan Market Value Proportion Analysis, 2022
  • Figure 175: Japan Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 176: Japan Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 177: Japan Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 178: Japan Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 179: South Korea Market Value Proportion Analysis, 2022
  • Figure 180: South Korea Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 181: South Korea Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 182: South Korea Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 183: South Korea Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 184: Oceania Mammalian Cell Banking Value Share By Cell 2023 (E)
  • Figure 185: Oceania Mammalian Cell Banking Value Share By Technology 2023 (E)
  • Figure 186: Oceania Mammalian Cell Banking Value Share By Application 2023 (E)
  • Figure 187: Oceania Mammalian Cell Banking Value Share End User 2023 (E)
  • Figure 188: Oceania Mammalian Cell Banking Value Share By Country 2023 (E)
  • Figure 189: Oceania Mammalian Cell Banking Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 190: Oceania Mammalian Cell Banking Current And Future Market Size (US$ Mn), 2023-2033 & Y-O-Y Growth Trend Analysis
  • Figure 191: Oceania Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 192: Oceania Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 193: Oceania Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 194: Oceania Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 195: Oceania Mammalian Cell Banking Attractiveness Analysis By Country, 2023-2033
  • Figure 196: Australia Market Value Proportion Analysis, 2022
  • Figure 197: Australia Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 198: Australia Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 199: Australia Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 200: Australia Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 201: New Zealand Market Value Proportion Analysis, 2022
  • Figure 202: New Zealand Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 203: New Zealand Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 204: New Zealand Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 205: New Zealand Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 206: Middle East & Africa Mammalian Cell Banking Value Share By Cell 2023 (E)
  • Figure 207: Middle East & Africa Mammalian Cell Banking Value Share By Technology 2023 (E)
  • Figure 208: Middle East & Africa Mammalian Cell Banking Value Share By Application 2023 (E)
  • Figure 209: Middle East & Africa Mammalian Cell Banking Value Share End User 2023 (E)
  • Figure 210: Middle East & Africa Mammalian Cell Banking Value Share By Country 2023 (E)
  • Figure 211: Middle East & Africa Mammalian Cell Banking Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 212: Middle East & Africa Mammalian Cell Banking Current and Future Market Size (US$ Mn), 2023-2033 & Y-O-Y Growth Trend Analysis
  • Figure 213: Middle East & Africa Mammalian Cell Banking Attractiveness Analysis By Cell, 2023-2033
  • Figure 214: Middle East & Africa Mammalian Cell Banking Attractiveness Analysis By Technology, 2023-2033
  • Figure 215: Middle East & Africa Mammalian Cell Banking Attractiveness Analysis By Application, 2023-2033
  • Figure 216: Middle East & Africa Mammalian Cell Banking Attractiveness Analysis End User, 2023-2033
  • Figure 217: Middle East & Africa Mammalian Cell Banking Attractiveness Analysis By Country, 2023-2033
  • Figure 218: GCC Countries Market Value Proportion Analysis, 2022
  • Figure 219: GCC Countries Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 220: GCC Countries Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 221: GCC Countries Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 222: GCC Countries Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 223: Turkey Market Value Proportion Analysis, 2022
  • Figure 224: Turkey Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 225: Turkey Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 226: Turkey Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 227: Turkey Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 228: South Africa Market Value Proportion Analysis, 2022
  • Figure 229: South Africa Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 300: South Africa Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 311: South Africa Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 312: South Africa Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
  • Figure 313: North Africa Market Value Proportion Analysis, 2022
  • Figure 314: North Africa Mammalian Cell Banking Share Analysis (%), By Cell, 2022 & 2033
  • Figure 315: North Africa Mammalian Cell Banking Share Analysis (%), By Technology, 2022 & 2033
  • Figure 316: North Africa Mammalian Cell Banking Share Analysis (%), By Application, 2022 & 2033
  • Figure 317: North Africa Mammalian Cell Banking Share Analysis (%), End User, 2022 & 2033
目次
Product Code: PMRREP31663

Global Mammalian Cell Banking Market: Scope of the Report

The latest publication by Persistence Market Research on the global mammalian cell banking market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for global mammalian cell banking market and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the global mammalian cell banking market. Shareholders in the mammalian cell banking market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the mammalian cell banking market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the global mammalian cell banking market offers information divided into five important segments - cell, technology, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Cell

CHO

BHK

NS0

YB2/0 & P2/0

HEK293 & Derivatives

HELA

Technology

TEP

IEP

SEP

Application

MCB

WCB

EoP

R&D CB

End User

Academic & Research Institute

Biopharmaceutical Companies

CROs

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for mammalian cell banking over the coming years?

How will changing trends impact the market?

How has the COVID-19 crisis affected market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will impact the market?

How can companies in the mammalian cell banking market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the mammalian cell banking market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the mammalian cell banking market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development/Innovation Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Value chain Analysis
  • 4.3. Key Promotional Strategies, By Key Manufacturers
  • 4.4. Regulatory Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cell Banking Outsourcing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Increasing Geriatric Population
    • 5.2.4. Rising Cases of Cancer
    • 5.2.5. Growing Preference of Mammalian Cell Banking
    • 5.2.6. Increased R&D investments by Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Cell
    • 6.1.2. By Technology
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2022 Market Scenario

7. Global Mammalian Cell Banking Market Demand Value or Size in (US$ Mn) Analysis 2015 - 2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015 - 2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033, By Cell

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2015 - 2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2023-2033
    • 8.3.1. CHO
    • 8.3.2. BHK
    • 8.3.3. NS0
    • 8.3.4. YB2/0 & P2/0
    • 8.3.5. HEK293 & Derivatives
    • 8.3.6. HELA
  • 8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033, By Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Technology, 2015 - 2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2023-2033
    • 9.3.1. TEP
    • 9.3.2. IEP
    • 9.3.3. SEP
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2015 - 2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023-2033
    • 10.3.1. MCB
    • 10.3.2. WCB
    • 10.3.3. EoP
    • 10.3.4. R&D CB
  • 10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By End User, 2015 - 2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023-2033
    • 11.3.1. Academic & Research Institute
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. CROs
  • 11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2015 - 2022
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2023-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2022
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Cell
    • 13.3.3. By Technology
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Cell
    • 13.4.3. By Technology
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Mammalian Cell Banking Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Cell
        • 13.8.1.2.2. By Technology
        • 13.8.1.2.3. By Application
        • 13.8.1.2.4. By End User
    • 13.8.2. Canada Mammalian Cell Banking Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Cell
        • 13.8.2.2.2. By Technology
        • 13.8.2.2.3. By Application
        • 13.8.2.2.4. By End User

14. Latin America Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2022
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Cell
    • 14.3.3. By Technology
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Cell
    • 14.4.3. By Technology
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Mammalian Cell Banking Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Cell
        • 14.8.1.2.2. By Technology
        • 14.8.1.2.3. By Application
        • 14.8.1.2.4. By End User
    • 14.8.2. Brazil Mammalian Cell Banking Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Cell
        • 14.8.2.2.2. By Technology
        • 14.8.2.2.3. By Application
        • 14.8.2.2.4. By End User
    • 14.8.3. Argentina Mammalian Cell Banking Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Cell
        • 14.8.3.2.2. By Technology
        • 14.8.3.2.3. By Application
        • 14.8.3.2.4. By End User

15. Europe Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2022
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. Italy
      • 15.3.1.2. Germany
      • 15.3.1.3. U.K
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Nordic Countries
      • 15.3.1.8. Russia
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Cell
    • 15.3.3. By Technology
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Cell
    • 15.4.3. By Technology
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Italy Mammalian Cell Banking Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Cell
        • 15.8.1.2.2. By Technology
        • 15.8.1.2.3. By Application
        • 15.8.1.2.4. By End User
    • 15.8.2. Germany Mammalian Cell Banking Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Cell
        • 15.8.2.2.2. By Technology
        • 15.8.2.2.3. By Application
        • 15.8.2.2.4. By End User
    • 15.8.3. U.K. Mammalian Cell Banking Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Cell
        • 15.8.3.2.2. By Technology
        • 15.8.3.2.3. By Application
        • 15.8.3.2.4. By End User
    • 15.8.4. France Mammalian Cell Banking Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Cell
        • 15.8.4.2.2. By Technology
        • 15.8.4.2.3. By Application
        • 15.8.4.2.4. By End User
    • 15.8.5. Spain Mammalian Cell Banking Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Cell
        • 15.8.5.2.2. By Technology
        • 15.8.5.2.3. By Application
        • 15.8.5.2.4. By End User
    • 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Cell
        • 15.8.6.2.2. By Technology
        • 15.8.6.2.3. By Application
        • 15.8.6.2.4. By End User
    • 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Cell
        • 15.8.7.2.2. By Technology
        • 15.8.7.2.3. By Application
        • 15.8.7.2.4. By End User
    • 15.8.8. Russia Mammalian Cell Banking Market Analysis
      • 15.8.8.1. Introduction
      • 15.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.8.2.1. By Cell
        • 15.8.8.2.2. By Technology
        • 15.8.8.2.3. By Application
        • 15.8.8.2.4. By End User

16. South Asia Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2022
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Cell
    • 16.3.3. By Technology
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Cell
    • 16.4.3. By Technology
    • 16.4.4. By Application
    • 16.4.5. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Mammalian Cell Banking Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Cell
        • 16.8.1.2.2. By Technology
        • 16.8.1.2.3. By Application
        • 16.8.1.2.4. By End User
    • 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Cell
        • 16.8.2.2.2. By Technology
        • 16.8.2.2.3. By Application
        • 16.8.2.2.4. By End User
    • 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Cell
        • 16.8.3.2.2. By Technology
        • 16.8.3.2.3. By Application
        • 16.8.3.2.4. By End User
    • 16.8.4. Thailand Mammalian Cell Banking Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Cell
        • 16.8.4.2.2. By Technology
        • 16.8.4.2.3. By Application
        • 16.8.4.2.4. By End User

17. East Asia Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2022
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Cell
    • 17.3.3. By Technology
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Cell
    • 17.4.3. By Technology
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Mammalian Cell Banking Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Cell
        • 17.8.1.2.2. By Technology
        • 17.8.1.2.3. By Application
        • 17.8.1.2.4. By End User
    • 17.8.2. Japan Mammalian Cell Banking Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Cell
        • 17.8.2.2.2. By Technology
        • 17.8.2.2.3. By Application
        • 17.8.2.2.4. By End User
    • 17.8.3. South Korea Mammalian Cell Banking Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Cell
        • 17.8.3.2.2. By Technology
        • 17.8.3.2.3. By Application
        • 17.8.3.2.4. By End User

18. Oceania Mammalian Cell Banking Market 2015-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2022
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Cell
    • 18.3.3. By Technology
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Cell
    • 18.4.3. By Technology
    • 18.4.4. By Application
    • 18.4.5. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Mammalian Cell Banking Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Cell
        • 18.8.1.2.2. By Technology
        • 18.8.1.2.3. By Application
        • 18.8.1.2.4. By End User
    • 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Cell
        • 18.8.2.2.2. By Technology
        • 18.8.2.2.3. By Application
        • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Analysis 2015 - 2022 and Forecast 2023-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2022
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Cell
    • 19.3.3. By Technology
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Cell
    • 19.4.3. By Technology
    • 19.4.4. By Application
    • 19.4.5. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Cell
        • 19.8.1.2.2. By Technology
        • 19.8.1.2.3. By Application
        • 19.8.1.2.4. By End User
    • 19.8.2. Turkey Mammalian Cell Banking Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Cell
        • 19.8.2.2.2. By Technology
        • 19.8.2.2.3. By Application
        • 19.8.2.2.4. By End User
    • 19.8.3. South Africa Mammalian Cell Banking Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Cell
        • 19.8.3.2.2. By Technology
        • 19.8.3.2.3. By Application
        • 19.8.3.2.4. By End User
    • 19.8.4. North Africa Mammalian Cell Banking Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Cell
        • 19.8.4.2.2. By Technology
        • 19.8.4.2.3. By Application
        • 19.8.4.2.4. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional Footprint of Players
    • 20.3.2. Cell Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Eurofins DiscoverX Corporation
      • 21.3.1.1. Overview
      • 21.3.1.2. Product & Services Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. SWOT Analysis
      • 21.3.1.5. Key Developments
      • 21.3.1.6. Sales Footprint
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Merck KGaA
      • 21.3.2.1. Overview
      • 21.3.2.2. Product & Services Portfolio
      • 21.3.2.3. Key Financials
      • 21.3.2.4. SWOT Analysis
      • 21.3.2.5. Key Developments
      • 21.3.2.6. Sales Footprint
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Sartorius Stedim BioOutsource Limited.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product & Services Portfolio
      • 21.3.3.3. Key Financials
      • 21.3.3.4. SWOT Analysis
      • 21.3.3.5. Key Developments
      • 21.3.3.6. Sales Footprint
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. Charles River Laboratories
      • 21.3.4.1. Overview
      • 21.3.4.2. Product & Services Portfolio
      • 21.3.4.3. Key Financials
      • 21.3.4.4. SWOT Analysis
      • 21.3.4.5. Key Developments
      • 21.3.4.6. Sales Footprint
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Altogen Labs
      • 21.3.5.1. Overview
      • 21.3.5.2. Product & Services Portfolio
      • 21.3.5.3. Key Financials
      • 21.3.5.4. SWOT Analysis
      • 21.3.5.5. Key Developments
      • 21.3.5.6. Sales Footprint
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. Abzena Ltd
      • 21.3.6.1. Overview
      • 21.3.6.2. Product & Services Portfolio
      • 21.3.6.3. Key Financials
      • 21.3.6.4. SWOT Analysis
      • 21.3.6.5. Key Developments
      • 21.3.6.6. Sales Footprint
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. Northway Biotechpharma
      • 21.3.7.1. Overview
      • 21.3.7.2. Product & Services Portfolio
      • 21.3.7.3. Key Financials
      • 21.3.7.4. SWOT Analysis
      • 21.3.7.5. Key Developments
      • 21.3.7.6. Sales Footprint
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. Lonza Group Ltd
      • 21.3.8.1. Overview
      • 21.3.8.2. Product & Services Portfolio
      • 21.3.8.3. Key Financials
      • 21.3.8.4. SWOT Analysis
      • 21.3.8.5. Key Developments
      • 21.3.8.6. Sales Footprint
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy
    • 21.3.9. VIRUSURE
      • 21.3.9.1. Overview
      • 21.3.9.2. Product & Services Portfolio
      • 21.3.9.3. Key Financials
      • 21.3.9.4. SWOT Analysis
      • 21.3.9.5. Key Developments
      • 21.3.9.6. Sales Footprint
      • 21.3.9.7. Strategy Overview
        • 21.3.9.7.1. Marketing Strategy
        • 21.3.9.7.2. Product Strategy
        • 21.3.9.7.3. Channel Strategy
    • 21.3.10. Selexis SA
      • 21.3.10.1. Overview
      • 21.3.10.2. Product & Services Portfolio
      • 21.3.10.3. Key Financials
      • 21.3.10.4. SWOT Analysis
      • 21.3.10.5. Key Developments
      • 21.3.10.6. Sales Footprint
      • 21.3.10.7. Strategy Overview
        • 21.3.10.7.1. Marketing Strategy
        • 21.3.10.7.2. Product Strategy
        • 21.3.10.7.3. Channel Strategy
    • 21.3.11. Sigma-Aldrich
      • 21.3.11.1. Overview
      • 21.3.11.2. Product & Services Portfolio
      • 21.3.11.3. Key Financials
      • 21.3.11.4. SWOT Analysis
      • 21.3.11.5. Key Developments
      • 21.3.11.6. Sales Footprint
      • 21.3.11.7. Strategy Overview
        • 21.3.11.7.1. Marketing Strategy
        • 21.3.11.7.2. Product Strategy
        • 21.3.11.7.3. Channel Strategy
    • 21.3.12. Takara Bio Inc
      • 21.3.12.1. Overview
      • 21.3.12.2. Product & Services Portfolio
      • 21.3.12.3. Key Financials
      • 21.3.12.4. SWOT Analysis
      • 21.3.12.5. Key Developments
      • 21.3.12.6. Sales Footprint
      • 21.3.12.7. Strategy Overview
        • 21.3.12.7.1. Marketing Strategy
        • 21.3.12.7.2. Product Strategy
        • 21.3.12.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology